Ghislaine Sierankowski
- Oncology
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Cancer Research
- Pathology and Forensic Medicine
- Co-authors
- Jean‐Michel CoindreIsabelle HosteinLouis GuillouManuela PelmusGaëtan MacGroganL. MauriacMarc DebledVéronique Brouste
- Topics
- Breast Cancer Treatment Studies (2 papers)HER2/EGFR in Cancer Research (2 papers)Cancer therapeutics and mechanisms (1 paper)
- Journals
- British Journal of CancerInternational Journal of CancerThe American Journal of Surgical Pathology
- Partner nations
- FranceSwitzerlandGermany
In The Last Decade
Ghislaine Sierankowski
7 papers receiving 376 citations
Peers
Comparison fields: 5 of 52
- Oncology 218
- Pulmonary and Respiratory Medicine 175
- Molecular Biology 125
- Cancer Research 88
- Pathology and Forensic Medicine 75
Countries citing papers authored by Ghislaine Sierankowski
This map shows the geographic impact of Ghislaine Sierankowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghislaine Sierankowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghislaine Sierankowski more than expected).
Fields of papers citing papers by Ghislaine Sierankowski
This network shows the impact of papers produced by Ghislaine Sierankowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghislaine Sierankowski. The network helps show where Ghislaine Sierankowski may publish in the future.
Co-authorship network of co-authors of Ghislaine Sierankowski
This figure shows the co-authorship network connecting the top 25 collaborators of Ghislaine Sierankowski. A scholar is included among the top collaborators of Ghislaine Sierankowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghislaine Sierankowski. Ghislaine Sierankowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 44 | |
| 3 | 40 | |
| 4 | 18 | |
| 5 | 78 | |
| 6 | 164 | |
| 7 | Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma. | 37 |
About Ghislaine Sierankowski
Ghislaine Sierankowski is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 7 papers that have together received 386 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (218 citations), Cancer Research (88 citations) and Pulmonary and Respiratory Medicine (175 citations). Ghislaine Sierankowski has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include Jean‐Michel Coindre, Isabelle Hostein, Louis Guillou, Manuela Pelmus, Gaëtan MacGrogan, L. Mauriac, Marc Debled, Véronique Brouste, Simone Mathoulin‐Pélissier and Isabelle de Mascarel. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.